GF

Tailored Cancer Treatment: VUB Research Predicts Which Patients Benefit from Immunotherapy

A team of scientists led by researchers from the Vrije Universiteit Brussel (VUB) and the Flemish Institute for Biotechnology (VIB) has developed a new technology to precisely predict and monitor cancer patients' responses to immunotherapy.

VUB research on HIV leads to innovative mRNA vaccine: a new therapeutic perspective for HIV patients

Researchers from Vrije Universiteit Brussel (VUB), University Hospital Brussels (UZ Brussel), and Ghent University (UGent) have made a significant breakthrough in developing a new therapeutic HIV vaccine. Their study, published in Molecular Therapy: Nucleic Acids, demonstrates the effectiveness of an mRNA-based vaccine encapsulated in lipid nanoparticles to enhance the immune system, potentially reducing the reliance on traditional antiretroviral therapies.

VUB Researchers Wear Purple on World Pancreatic Cancer Day to Raise Awareness About Deadly Disease

Brussels, November 21, 2024 – Today marks World Pancreatic Cancer Day. Researchers from VUB (Vrije Universiteit Brussel) wear purple to show solidarity and raise awareness about this aggressive disease. At the same time, their research offers hope for better diagnostics and treatments.

VUB researcher Mathieu Vinken was awarded the prestigious 5-yearly "Prize Dr. Monique Govaerts and Joseph Lepoix for the study of intoxications"

VUB Researchers Develop Safety Mechanism for Stem Cell Therapy

VUB research on immunotherapy for multiple myeloma establishes baseline for improved long-term success

Koen Putman Appointed as New Dean of VUB Faculty of Medicine and Pharmacy

BRUSSELS, June 24, 2024 (11:30 a.m. CEST) - The Faculty of Medicine and Pharmacy at VUB has elected a new dean. With 87% of the votes, Prof. Dr. Koen Putman was chosen as dean and will lead the Faculty from the academic year 2024-2025 at the Brussels Health Campus.

UZ Brussel-VUB receive €2.5m for research into pioneering cancer treatment technique

The Vrije Universiteit Brussel and UZ Brussel have been awarded a €2.5 million grant to further research FLASH radiation. This new technique means that a cancer patient needs to be treated with radiation only once, instead of dozens of time. The research will first be offered to people with skin cancer, rectal cancer and sarcomas. VUB’s Research Centre for Digital Medicine and the Radiotherapy department at UZ Brussel, led by Prof Mark De Ridder and Prof Thierry Gevaert, have received the prestigious grant for large-scale research infrastructure from the Research Foundation – Flanders (FWO). It will enable the Radiotherapy department to offer the new treatment in Belgium within a year.

How do food and lifestyle affect brain health? 

VUB researchers show xCT protein is key link in inhibiting pancreatic cancer growth and limiting mood disturbances

VUB researchers design medicine of the future

Newly discovered protein blocks sleeping sickness